| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| China | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 499,807.73 | 4,444,280 | Kg |
| European Union | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 472,932.91 | 6,519,850 | Kg |
| Germany | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 261,877.17 | 4,283,320 | Kg |
| Italy | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 113,465.68 | 1,232,080 | Kg |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 97,677.27 | | |
| France | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 64,782.02 | 227,158 | Kg |
| Norway | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 55,035.43 | 162,538 | Kg |
| Switzerland | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 25,525.44 | 45,013 | Kg |
| Ireland | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 16,394.99 | 520,691 | Kg |
| Netherlands | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 6,027.98 | 135,019 | Kg |
| Denmark | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 4,974.19 | 1,404 | Kg |
| Luxembourg | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 3,752.59 | 112,345 | Kg |
| Belgium | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 1,272.41 | 891 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 498.95 | 408 | Kg |
| India | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 138.76 | 469 | Kg |
| Hungary | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 34.45 | 6,242 | Kg |
| Uruguay | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 25.49 | 1 | Kg |
| New Zealand | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 25.05 | 229 | Kg |
| Japan | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 20.12 | 14 | Kg |
| Korea, Rep. | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 17.39 | 313 | Kg |
| Philippines | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 15.29 | 28 | Kg |
| Austria | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 9.50 | 167 | Kg |
| Brazil | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 8.25 | 28 | Kg |
| Portugal | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 3.39 | 87 | Kg |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 2.17 | | |
| Thailand | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 0.57 | 34 | Kg |
| Dominican Republic | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 0.26 | 1 | Kg |
| Indonesia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 0.20 | 3 | Kg |
| Costa Rica | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 0.10 | 1 | Kg |
| Brunei | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 0.05 | 8 | Kg |
